The Beauty Health Company (SKIN)
|52 Week Range||8.25-19.38|
|1y Target Est||-|
|DCF Unlevered||SKIN DCF ->|
|DCF Levered||SKIN LDCF ->|
|Debt / Equity||488.37%||Strong Buy|
Upgrades & Downgrades
Latest SKIN news
Why Is The Beauty Health Company Jumping Higher Today?
28 February 2023
The medical device company is gaining traction with growing sales and profits.
7 Short-Squeeze Stocks to Buy Before They Soar
30 January 2023
As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries catharti...
The Beauty Health Company: A Good Long Term Bet
19 January 2023
In 2023, revenue should benefit from healthy demand and an increasing footprint globally. Margins should benefit from operating leverage and normalized investment levels in 2023.
The Beauty Health Company (SKIN) Q3 2022 Earnings Call Transcript
8 November 2022
The Beauty Health Company (NASDAQ:SKIN ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director of M&A and IR Andrew Stanleick - Presiden...
The Beauty Health Company: A Compelling Mid To Long-Term Growth Story
12 October 2022
The Beauty Health Company's new mid-term targets highlight the impressive (but achievable) growth opportunities at hand. As the model benefits from operating leverage, more revenue growth should yield...
This High-Growth, Under-the-Radar Stock Has 80% Upside, According to Wall Street
4 October 2022
BeautyHealth's HydraFacial platform is popular, management is building a solid track record, and the business is outperforming expectations.
The Beauty Health Company (SKIN) Stock Jumps 11.4%: Will It Continue to Soar?
28 September 2022
The Beauty Health Company (SKIN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further ...
Here's Why BeautyHealth Stock Soared Today
27 September 2022
The company is going to repurchase millions of shares in just a couple of days.
Why Farfetch Limited, DoorDash, and The Beauty Health Company Soared Today
10 August 2022
A softer-than-feared inflation report lit a fire under beaten-down consumer discretionary names.
The Beauty Health Company (SKIN) CEO Andrew Stanleick on Q2 2022 Results - Earnings Call Transcript
9 August 2022
The Beauty Health Company (NASDAQ:SKIN ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director of M&A and Investor Relations Andrew Stanle...
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >